<PAGE> 1
As filed with the Securities and Exchange Commission on November _, 1999
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
---------------
SAGE, INC.
(Exact Name of Registrant as Specified in Its Charter)
DELAWARE 77-0389091
(State of Incorporation or Organization) (I.R.S. Employer
Identification Number)
2460 NORTH FIRST STREET, SUITE 100
SAN JOSE, CALIFORNIA 95131-1023
(Address of Principal Executive Offices) (Zip Code)
SECURITIES ACT REGISTRATION STATEMENT FILE NUMBER TO WHICH THIS FORM
RELATES: 333-83665
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
NAME OF EACH EXCHANGE ON WHICH
TITLE OF EACH CLASS TO BE REGISTERED EACH CLASS IS TO BE REGISTERED
------------------------------------ ------------------------------
Not Applicable Not Applicable
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
Common Stock
$.01 Par Value
<PAGE> 2
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
Incorporated herein by reference to the Registrant's Registration
Statement on Form S-1 (File No. 333-86173, as amended) (the "Registration
Statement").
ITEM 2. EXHIBITS.
<TABLE>
<CAPTION>
EXHIBIT DESCRIPTION
------- -----------
<S> <C>
1.1 Specimen of Common Stock certificate of the Registrant.
Incorporated herein by reference to Exhibit 4.5 to the
Registrant's Registration Statement.
2.1 Certificate of Incorporation of the Registrant, as
amended. Incorporated herein by reference to Exhibit 3.1
to the Registrant's Registration Statement.
2.2 Bylaws of the Registrant. Incorporated herein by
reference to Exhibit 3.2.
2.3 Faroudja Laboratories, Inc. Investors' Rights Agreement.
Incorporated herein by reference to Exhibit 4.4 to the
Registrant's Registration Statement.
</TABLE>
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereto duly authorized.
Date: November 4, 1999
SAGE, INC.
By: /s/ Simon Westbrook
----------------------------------
Simon Westbrook
Chief Financial Officer
